February 1, 2021 – Medtronic plc (Dublin, Ireland) announced expansion of its limited site release of the recently acquired radial artery access portfolio from privately-held RIST Neurovascular, Inc., which includes the Rist 079 Radial Access Guide Catheter and Rist Radial Access Selective Catheter.
Terms of the acquisition were not disclosed.
The addition of the Rist 079 Radial Access Guide Catheter and Selective Catheter to the Medtronic neurovascular portfolio enhances the company’s ability to serve patients that require interventional neurovascular therapy. Rist 079 Radial Access Guide Catheter and Rist Radial Access Selective Catheter received U.S. Food and Drug Administration (FDA) 501(k) clearance last year.1
The acquisition of RIST Neurovascular, Inc., closed in August 2020 and is the eighth in a series of tuck-in acquisitions Medtronic has announced since January 2020. The revenue and earnings contribution is expected to be immaterial to the Medtronic Neurovascular business in the first two years and accretive thereafter. In addition, this transaction is expected to meet Medtronic’s long-term financial metrics for acquisitions.